Cargando…
Effect of Alpha-Lipoic Acid Supplementation on Endothelial Function and Cardiovascular Risk Factors in Overweight/Obese Youths: A Double-Blind, Placebo-Controlled Randomized Trial
Endothelial dysfunction is recognized as an early sign of systemic atherosclerosis, and it represents a therapeutic target to prevent long-term cardiovascular (CV) consequences. Alpha-lipoic acid (ALA) is a commonly used dietary supplement exerting anti-oxidant and anti-inflammatory effects. We inve...
Autores principales: | Tromba, Luciana, Perla, Francesco Massimo, Carbotta, Giovanni, Chiesa, Claudio, Pacifico, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412308/ https://www.ncbi.nlm.nih.gov/pubmed/30759784 http://dx.doi.org/10.3390/nu11020375 |
Ejemplares similares
-
Carotid Extra-Media Thickness in Children: Relationships With Cardiometabolic Risk Factors and Endothelial Function
por: Pacifico, Lucia, et al.
Publicado: (2020) -
Nonalcoholic Fatty Liver Disease Is Associated With Low Skeletal Muscle Mass in Overweight/Obese Youths
por: Pacifico, Lucia, et al.
Publicado: (2020) -
Effect of Alpha-Lipoic Acid Supplementation on Low-Grade Squamous Intraepithelial Lesions—Double-Blind, Randomized, Placebo-Controlled Trial
por: Divković, Anja, et al.
Publicado: (2022) -
Does Alpha-lipoic Acid Supplement Regulate Blood Pressure? A Systematic Review of Randomized, Double-blind Placebo-controlled Clinical Trials
por: Mohammadi, Vida, et al.
Publicado: (2017) -
Effects of alpha lipoic acid supplementation on serum lipid profile in patients with metabolic syndrome: A randomized, double-blind, placebo-controlled clinical trial
por: Ahmadi, Mahbubeh, et al.
Publicado: (2022)